Webinar #4

Innovative strategies to advance severe TBI treatment

12.10.2021, 12:00 – 13:30 (CEST)

Video(s)

Webinar-Video (english)

Until the advent of the successful CAPTAIN-trials with Cerebrolysin, one of the most important unmet needs in medicine has been the treatment of severe and moderate traumatic brain injury with evidence-based pharmacological agents.
Our speakers will present to you with innovative preclinical and clinical treatment concepts for severe TBI patients, innovative educational programs focusing on this highly complex medical problem and innovative biometric approaches solving the historical trial design failures in TBI trials.

Program

  • Chair/Moderation

    Johannes Vester

    New vistas in TBI clinical research - on the way towards a new gold standard

    15 min

    Johannes C. Vester

    Best supportive care in TBI: new hope from combined neuroprotective agents?

    20 min

    Helmut Trimmel

    Post Intensive Care Syndrome: neurotrophic factor hypothesis

    20 min

    Ignacio J. Previgliano

    Innovative concepts for increasing awareness of multidisciplinary treatment after TBI.

    20 min

    Peter Lackner
Johannes C. Vester
Head Biometry & Clinical Research
IDV Data Analysis and Study Planning, Gauting, Germany

Helmut Trimmel
Head of Anaesthesia, Emergency and General Intensive Care Medicine

Landesklinikum Wiener Neustadt, Austria

Ignacio J. Previgliano
Hospital General de Agudos J. A. Fernández
Buenos Aires City – Argentina

Peter Lackner
Head of Department of Neurology, Clinic Floridsdorf, Vienna, Austria